Streetbeat News

Analyst Ratings

CPT

INVH

LGIH

Analysts have adjusted their ratings and forecasts for three real estate stocks. Camden Property Trust and Invitation Homes were downgraded by RBC Capital Markets due to concerns about future performance and market conditions. LGI Homes was upgraded by Wedbush due to strong sales absorption and potential positive cash flow.

Portfolio Pulse from Priya Nigam

September 09, 2024 | 4:18 pm

VERA

Cantor Fitzgerald analyst Pete Stavropoulos has reiterated an Overweight rating on Vera Therapeutics (NASDAQ:VERA) and maintained a price target of $107.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:17 pm

DHR

Recent options trading trends for Danaher (NYSE:DHR) show a bearish sentiment among financial giants, with 53% of trades being bearish. The trading activity suggests a price target range of $95 to $290. Analysts have adjusted their ratings, with Wells Fargo downgrading to Equal-Weight and RBC Capital lowering to Outperform.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 4:15 pm

SPRY

Cantor Fitzgerald analyst Josh Schimmer has reiterated an Overweight rating on ARS Pharmaceuticals (NASDAQ:SPRY) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:15 pm

RNA

Cantor Fitzgerald has reiterated its Overweight rating on Avidity Biosciences, maintaining a price target of $96.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:08 pm

REGN

Cantor Fitzgerald has reiterated a Neutral rating for Regeneron Pharmaceuticals, maintaining a price target of $1015.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:06 pm

KR

Telsey Advisory Group has reiterated its 'Outperform' rating for Kroger, maintaining a price target of $62. This suggests confidence in Kroger's stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:04 pm

HLLY

Telsey Advisory Group has maintained an 'Outperform' rating on Holley (NYSE:HLLY) with a price target of $5.5, as stated by analyst Joseph Feldman.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:02 pm

XLE

XLU

Bank of America has adjusted its sector outlooks, upgrading Utilities to 'overweight' and downgrading Energy to 'market-weight'. Utilities, represented by XLU, are seen as a defensive hedge with growth potential due to stable fundamentals and AI integration. Energy, represented by XLE, faces political risks and negative earnings revisions, making it a less attractive investment.

Portfolio Pulse from Piero Cingari

September 09, 2024 | 4:02 pm

AXSM

Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 17 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $129.06, with a high of $180.00 and a low of $95.00. Recent ratings show a mix of 'Maintain', 'Raise', and 'Lower' actions, reflecting dynamic market conditions. Axsome's revenue growth is strong, but profitability metrics like net margin and ROE are below industry averages.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 4:01 pm